Azathioprine + Ustekinumab Ttwe Interaction
Moderateinteraction on record
Description
Immunomodulator used concomitantly in ~30% of CD/UC subjects; did not appear to influence overall safety or efficacy of ustekinumab.
Source: NLP:ustekinumab-ttwe
Immunomodulator used concomitantly in ~30% of CD/UC subjects; did not appear to influence overall safety or efficacy of ustekinumab.
Source: NLP:ustekinumab-ttwe